| 1 |
31479512 | Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. | 2020 Jun 1 |
1 |
| 2 |
29572009 | Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum. | 2018 Apr |
1 |
| 3 |
27893326 | Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET). | 2017 Feb |
3 |
| 4 |
27502726 | Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape. | 2016 Nov |
1 |
| 5 |
25028118 | Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients. | 2014 Dec |
2 |
| 6 |
25246386 | Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients. | 2014 Nov |
3 |
| 7 |
23482788 | Biomarkers as prognostic factors for cN2 or 3 non-small cell lung cancer treated by induction chemoradiotherapy and surgery. | 2013 Mar |
1 |
| 8 |
23523421 | Thymidylate synthase and ERCC1 as predictive markers in patients with pulmonary adenocarcinoma treated with pemetrexed and cisplatin. | 2013 Jul |
2 |
| 9 |
23790173 | Individualized treatment of NSCLC: from research to clinical practice. | 2013 |
1 |
| 10 |
23912706 | Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells. | 2013 Dec |
3 |
| 11 |
21262916 | Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin. | 2011 Apr 15 |
2 |